3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year Post author:Sam Post published:November 20, 2017 Post category:BioPharma Investors have had a decent year, but some have much to be grateful for this Thanksgiving. Source: BioSpace You Might Also Like Boehringer Inks €627.5M Deal With GlaxoSmithKline Spinout December 17, 2017 GlaxoSmithKline is Eyeing Pfizer's $15B+ Consumer Biz January 9, 2018 Argos Surges on Positive Phase III Kidney Cancer Data November 12, 2017